CUE
Cue Biopharma
25.60$
+1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.36 | 1.16 | 1.04 | 1.59 | 1.95 | 0.64 | 0.17 | 0.93 | 0.64 | 5.96 | 1.18 | 1.24 | 5.94 | |
| 5.81 | 8.58 | 0.51 | 5.70 | – | – | – | 0.03 | 0.02 | 0.87 | 0.02 | 0.01 | 0.54 | |
| -4.45 | -7.42 | 1.04 | 1.59 | 1.95 | 0.64 | 0.17 | 0.93 | 0.62 | 5.96 | 1.18 | 1.24 | 5.92 | |
| 6.39 | 6.93 | 6.19 | 5.70 | 5.49 | 2.90 | 3.45 | 2.49 | 1.39 | 4.49 | 1.43 | 7.73 | 12.16 | |
| 2.36 | 2.93 | 2.54 | 2.10 | 1.68 | 1.62 | 1.69 | 1.15 | 1.47 | 0.94 | 0.86 | 7.34 | 9.32 | |
| 2.94 | 1.38 | 8.72 | 7.80 | 7.12 | 4.53 | 5.14 | 3.64 | 2.86 | 5.42 | 2.30 | 15.07 | 21.48 | |
| -7.39 | -8.80 | -7.68 | -6.21 | -5.16 | -3.89 | -4.97 | -2.71 | -2.24 | 0.53 | -1.12 | -13.83 | -15.56 | |
| 0.19 | 0.32 | 0.15 | 0.13 | 0.11 | 0.06 | 0.05 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.02 | |
| -7.12 | -8.55 | -7.49 | -6.08 | -5.07 | -3.84 | -4.95 | -2.67 | -2.22 | 0.57 | -1.08 | -24.14 | -25.80 | |
| 0.45 | 0.51 | 0.49 | – | -5.07 | – | – | – | – | 0.14 | – | – | – | |
| -7.12 | -8.55 | -7.49 | -6.08 | -5.07 | -3.84 | -4.95 | -2.67 | -2.22 | 0.43 | -1.08 | -24.14 | -25.88 | |
| -6.85 | -8.63 | -6.83 | -5.44 | -4.45 | -3.74 | -4.54 | -2.40 | -2.17 | 0.91 | -0.88 | -13.83 | -15.12 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.